Market Overview

UPDATE: Bank of America Upgrades Vitamin Shoppe to Buy on Healthy and Sustainable Growth

Related VSI
UPDATE: Credit Suisse Upgrades GNC
UPDATE: Longbow Research Reiterates On Vitamin Shoppe Following 2Q EPS Beat

Bank of America raised its rating on Vitamin Shoppe (NYSE: VSI) from Neutral to Buy and upped its price objective from $65 to $67.

Bank of America noted, "VSI is a rare example of a recession-proof domestic growth story with ample square footage and international potential. Net income is forecast to grow by 25/20/19% from 2012-14 on the back of a 8%/6.5%/6.5% comp and ~9% square footage growth. Importantly, VSI's expected net income growth rate is nearly double that of its hardline peers (~10% per year from 2012-14E) which we believe will help support the company's premium multiple. In addition, with the company debt-free and net cash starting to mount, we believe share repurchases or a dividend could easily be accommodated despite its growth plans."

Vitamin Shoppe closed at $56.35 on Tuesday.

Posted-In: Bank of AmericaAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (VSI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters